Skip to main content
Erschienen in: Journal of Gastrointestinal Surgery 10/2016

04.08.2016 | Original Article

Diagnosis and Management of Oesophageal Cancer in Bariatric Surgical Patients

verfasst von: Paul R. Burton, Geraldine J. Ooi, Cheryl Laurie, Kalai Shaw, Paul E. O’Brien, Andrew Smith, Peter D. Nottle, Wendy A. Brown

Erschienen in: Journal of Gastrointestinal Surgery | Ausgabe 10/2016

Einloggen, um Zugang zu erhalten

Abstract

Background

Oesophageal cancer following bariatric surgery adds significant complexity to an already challenging disease. There is limited data on the diagnosis, presentation and management in these complex cases.

Methods

A retrospective cohort study on prospectively collected data over 10 years was conducted. The oesophago-gastric cancer database was searched for patients with prior bariatric surgery. Data were retrieved on bariatric and cancer management.

Results

We identified nine patients with oesophageal or gastro-oesophageal junction adenocarcinoma after bariatric surgery. Mean age was 58.3 ± 6.9 years, and duration from bariatric surgery was 13.2 ± 9.4 years. Weight loss at diagnosis was 30.6 ± 23.3 kg (excess weight loss 58.1 % ± 29.6). Modes of presentation were Barrett’s surveillance (n = 3), reflux symptoms (n = 4) and incidental (n = 2). Management was surgical resection (n = 4), endoscopic mucosal resection (n = 2) and palliative (n = 3). Surgical resections were challenging due to adhesions, obesity, luminal dilatation and scarring on the stomach. There were two substantial leaks following gastroplasty.

Conclusions

Oesophageal cancer following bariatric surgery is a challenging problem, and surgical resection carries high risk. A high index of suspicion is required and symptoms investigated precipitously. Technical challenges of operating on obese patients and the specific effects of previous bariatric procedures need to be understood, particularly the limitations on reconstructive options.
Literatur
1.
Zurück zum Zitat Rubenstein, JH and Shaheen, NJ. Epidemiology, Diagnosis, and Management of Esophageal Adenocarcinoma. Gastroenterology, 2015. 149(2): 302–17 e1. Rubenstein, JH and Shaheen, NJ. Epidemiology, Diagnosis, and Management of Esophageal Adenocarcinoma. Gastroenterology, 2015. 149(2): 302–17 e1.
2.
Zurück zum Zitat Pennathur, A, Gibson, MK, Jobe, BA, and Luketich, JD. Oesophageal carcinoma. Lancet, 2013. 381(9864): 400–12. Pennathur, A, Gibson, MK, Jobe, BA, and Luketich, JD. Oesophageal carcinoma. Lancet, 2013. 381(9864): 400–12.
3.
Zurück zum Zitat Byers, T and Sedjo, RL. Body fatness as a cause of cancer: epidemiologic clues to biologic mechanisms. Endocr Relat Cancer, 2015. 22(3): R125-34. Byers, T and Sedjo, RL. Body fatness as a cause of cancer: epidemiologic clues to biologic mechanisms. Endocr Relat Cancer, 2015. 22(3): R125-34.
4.
Zurück zum Zitat Scozzari, G, Trapani, R, Toppino, M, and Morino, M. Esophagogastric cancer after bariatric surgery: systematic review of the literature. Surg Obes Relat Dis, 2013. 9(1): 133–42. Scozzari, G, Trapani, R, Toppino, M, and Morino, M. Esophagogastric cancer after bariatric surgery: systematic review of the literature. Surg Obes Relat Dis, 2013. 9(1): 133–42.
5.
Zurück zum Zitat Cunningham, D, Allum, WH, Stenning, SP, Thompson, JN, Van de Velde, CJ, Nicolson, M, Scarffe, JH, Lofts, FJ, Falk, SJ, Iveson, TJ, Smith, DB, Langley, RE, Verma, M, Weeden, S, and Chua, YJ. Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer. N Engl J Med, 2006. 355(1): 11–20. Cunningham, D, Allum, WH, Stenning, SP, Thompson, JN, Van de Velde, CJ, Nicolson, M, Scarffe, JH, Lofts, FJ, Falk, SJ, Iveson, TJ, Smith, DB, Langley, RE, Verma, M, Weeden, S, and Chua, YJ. Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer. N Engl J Med, 2006. 355(1): 11–20.
6.
Zurück zum Zitat Cichowitz, A, Burton, P, Brown, W, Smith, A, Shaw, K, Slamowicz, R, and Nottle, PD. Ex vivo dissection increases lymph node yield in oesophagogastric cancer. ANZ J Surg. 2015;85(1–2):80–84. Cichowitz, A, Burton, P, Brown, W, Smith, A, Shaw, K, Slamowicz, R, and Nottle, PD. Ex vivo dissection increases lymph node yield in oesophagogastric cancer. ANZ J Surg. 2015;85(1–2):80–84.
7.
Zurück zum Zitat Tarnoff M, Kaplan LM, Shikora S. An evidence-based assessment of pre-operative weight loss in bariatric surgery. Obes Surg. 2008; 18:1059–61. Tarnoff M, Kaplan LM, Shikora S. An evidence-based assessment of pre-operative weight loss in bariatric surgery. Obes Surg. 2008; 18:1059–61.
8.
Zurück zum Zitat Ross R, Rissanen J, Pedwell H, Clifford J, Shragge P. Influence of diet and exercise on skeletal muscle and visceral adipose tissue in men. J Appl Physiol. 1996;81:2445–2455. Ross R, Rissanen J, Pedwell H, Clifford J, Shragge P. Influence of diet and exercise on skeletal muscle and visceral adipose tissue in men. J Appl Physiol. 1996;81:2445–2455.
9.
Zurück zum Zitat Colles SL, Dixon JB, Marks P, Strauss BJ, O’Brien PE. Preoperative weight loss with a very-low-energy diet: quantitation of changes in liver and abdominal fat by serial imaging. Am J Clin Nutr. 2006;84(2):304–311. Colles SL, Dixon JB, Marks P, Strauss BJ, O’Brien PE. Preoperative weight loss with a very-low-energy diet: quantitation of changes in liver and abdominal fat by serial imaging. Am J Clin Nutr. 2006;84(2):304–311.
10.
Zurück zum Zitat Brown WA, Moszkowicz J, Brennan L, Burton PR, Anderson M, O’Brien PE. Pre-operative weight loss does not predict weight loss following laparoscopic adjustable gastric banding. Obes Surg. 2013;23:1611–1615. Brown WA, Moszkowicz J, Brennan L, Burton PR, Anderson M, O’Brien PE. Pre-operative weight loss does not predict weight loss following laparoscopic adjustable gastric banding. Obes Surg. 2013;23:1611–1615.
12.
Zurück zum Zitat Sharaf, RN, Weinshel, EH, Bini, EJ, Rosenberg, J, Sherman, A, and Ren, CJ. Endoscopy plays an important preoperative role in bariatric surgery. Obes Surg, 2004. 14(10): 1367–72. Sharaf, RN, Weinshel, EH, Bini, EJ, Rosenberg, J, Sherman, A, and Ren, CJ. Endoscopy plays an important preoperative role in bariatric surgery. Obes Surg, 2004. 14(10): 1367–72.
13.
Zurück zum Zitat Loewen, M, Giovanni, J, and Barba, C. Screening endoscopy before bariatric surgery: A series of 448 patients. Surg Obes Relat Dis, 2008. 4(6): 709–12. Loewen, M, Giovanni, J, and Barba, C. Screening endoscopy before bariatric surgery: A series of 448 patients. Surg Obes Relat Dis, 2008. 4(6): 709–12.
14.
Zurück zum Zitat Whiteman, DC, Appleyard, M, Bahin, FF, Bobryshev, YV, Bourke, MJ, Brown, I, Chung, A, Clouston, A, Dickins, E, Emery, J, Eslick, GD, Gordon, LG, Grimpen, F, Hebbard, G, Holliday, L, Hourigan, LF, Kendall, BJ, Lee, EY, Levert-Mignon, A, Lord, RV, Lord, SJ, Maule, D, Moss, A, Norton, I, Olver, I, Pavey, D, Raftopoulos, S, Rajendra, S, Schoeman, M, Singh, R, Sitas, F, Smithers, BM, Taylor, AC, Thomas, ML, Thomson, I, To, H, von Dincklage, J, Vuletich, C, Watson, DI, and Yusoff, IF. Australian clinical practice guidelines for the diagnosis and management of Barrett’s esophagus and early esophageal adenocarcinoma. J Gastroenterol Hepatol, 2015. 30(5): 804–20. Whiteman, DC, Appleyard, M, Bahin, FF, Bobryshev, YV, Bourke, MJ, Brown, I, Chung, A, Clouston, A, Dickins, E, Emery, J, Eslick, GD, Gordon, LG, Grimpen, F, Hebbard, G, Holliday, L, Hourigan, LF, Kendall, BJ, Lee, EY, Levert-Mignon, A, Lord, RV, Lord, SJ, Maule, D, Moss, A, Norton, I, Olver, I, Pavey, D, Raftopoulos, S, Rajendra, S, Schoeman, M, Singh, R, Sitas, F, Smithers, BM, Taylor, AC, Thomas, ML, Thomson, I, To, H, von Dincklage, J, Vuletich, C, Watson, DI, and Yusoff, IF. Australian clinical practice guidelines for the diagnosis and management of Barrett’s esophagus and early esophageal adenocarcinoma. J Gastroenterol Hepatol, 2015. 30(5): 804–20.
15.
Zurück zum Zitat Coe, PO, O’Reilly, DA, and Renehan, AG. Excess adiposity and gastrointestinal cancer. Br J Surg, 2014. 101(12): 1518–31. Coe, PO, O’Reilly, DA, and Renehan, AG. Excess adiposity and gastrointestinal cancer. Br J Surg, 2014. 101(12): 1518–31.
16.
Zurück zum Zitat De Pergola, G and Silvestris, F. Obesity as a major risk factor for cancer. J Obes, 2013. 2013: 291546. De Pergola, G and Silvestris, F. Obesity as a major risk factor for cancer. J Obes, 2013. 2013: 291546.
17.
Zurück zum Zitat Chiba, T, Marusawa, H, and Ushijima, T. Inflammation-associated cancer development in digestive organs: mechanisms and roles for genetic and epigenetic modulation. Gastroenterology, 2012. 143(3): 550–63. Chiba, T, Marusawa, H, and Ushijima, T. Inflammation-associated cancer development in digestive organs: mechanisms and roles for genetic and epigenetic modulation. Gastroenterology, 2012. 143(3): 550–63.
18.
Zurück zum Zitat Aleman, JO, Eusebi, LH, Ricciardiello, L, Patidar, K, Sanyal, AJ, and Holt, PR. Mechanisms of obesity-induced gastrointestinal neoplasia. Gastroenterology, 2014. 146(2): 357–73. Aleman, JO, Eusebi, LH, Ricciardiello, L, Patidar, K, Sanyal, AJ, and Holt, PR. Mechanisms of obesity-induced gastrointestinal neoplasia. Gastroenterology, 2014. 146(2): 357–73.
19.
Zurück zum Zitat Birks, S, Peeters, A, Backholer, K, O’Brien, P, and Brown, W. A systematic review of the impact of weight loss on cancer incidence and mortality. Obes Rev, 2012. 13(10): 868–91. Birks, S, Peeters, A, Backholer, K, O’Brien, P, and Brown, W. A systematic review of the impact of weight loss on cancer incidence and mortality. Obes Rev, 2012. 13(10): 868–91.
20.
Zurück zum Zitat Peeters, A, O’Brien, PE, Laurie, C, Anderson, M, Wolfe, R, Flum, D, MacInnis, RJ, English, DR, and Dixon, J. Substantial intentional weight loss and mortality in the severely obese. Ann Surg, 2007. 246(6): 1028–33. Peeters, A, O’Brien, PE, Laurie, C, Anderson, M, Wolfe, R, Flum, D, MacInnis, RJ, English, DR, and Dixon, J. Substantial intentional weight loss and mortality in the severely obese. Ann Surg, 2007. 246(6): 1028–33.
21.
Zurück zum Zitat Yang, XW, Li, PZ, Zhu, LY, and Zhu, S. Effects of bariatric surgery on incidence of obesity-related cancers: a meta-analysis. Med Sci Monit, 2015. 21: 1350–7. Yang, XW, Li, PZ, Zhu, LY, and Zhu, S. Effects of bariatric surgery on incidence of obesity-related cancers: a meta-analysis. Med Sci Monit, 2015. 21: 1350–7.
22.
Zurück zum Zitat Australian Institute of Health and Welfare, Australasian Association of Cancer Registries, Cancer in Australia: An overview, 2012, in Cancer series no. 74. 2012: Canberra: AIHW. Australian Institute of Health and Welfare, Australasian Association of Cancer Registries, Cancer in Australia: An overview, 2012, in Cancer series no. 74. 2012: Canberra: AIHW.
Metadaten
Titel
Diagnosis and Management of Oesophageal Cancer in Bariatric Surgical Patients
verfasst von
Paul R. Burton
Geraldine J. Ooi
Cheryl Laurie
Kalai Shaw
Paul E. O’Brien
Andrew Smith
Peter D. Nottle
Wendy A. Brown
Publikationsdatum
04.08.2016
Verlag
Springer US
Erschienen in
Journal of Gastrointestinal Surgery / Ausgabe 10/2016
Print ISSN: 1091-255X
Elektronische ISSN: 1873-4626
DOI
https://doi.org/10.1007/s11605-016-3221-0

Weitere Artikel der Ausgabe 10/2016

Journal of Gastrointestinal Surgery 10/2016 Zur Ausgabe

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

CME: 2 Punkte

Prof. Dr. med. Gregor Antoniadis Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

CME: 2 Punkte

Dr. med. Benjamin Meyknecht, PD Dr. med. Oliver Pieske Das Webinar S2e-Leitlinie „Distale Radiusfraktur“ beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

CME: 2 Punkte

Dr. med. Mihailo Andric
Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.